Lastly, despite some data indicating no association between cytogenetics and TET2 status in MPN, TET2 mutations occur more often in the presence of normal karyotype and intermediate-risk AML (Hussein et al., 2010; Weissmann et al., 2012). Here, TET2 is linked to acute myeloid leukemia.